SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Paracelsian Inc (PRLN)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Rick Costantino who wrote (3272)9/15/1997 3:04:00 PM
From: Richard Mazzarella   of 4342
 
Rick, I agree with you that the market may view the departure of Rhodes well. I bought back into this stock today based on that potential. Rhodes had himself maintained that he didn't want the job when they formed a committee to find his successor. He sure proved how much he didn't want the job. This company has technology and experimental results that should find value for takeover by another biotech IMO. They either need to fix it or sell it. If they could get Babish back I think the stock would get to $2 quickly. Even if they can't get him back we should be able to get at least $1/share from a buyout. Comments?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext